Comparison of Capox and Folfox with or Without Irinotecan in Colorectal Cancer

IJSRP, Volume 10, Issue 8, August 2020 Edition [ISSN 2250-3153]

Comparison of Capox and Folfox with or Without Irinotecan in Colorectal Cancer

Karthika V Chandran, Maddili Manoj Kumar, Sankaraneni Manusha, Shirnam Shailja

Abstract: Colorectal cancer is cancer that occurs in the rectum or colon. Colon cancer and rectal cancer are often put together because they have many similar features. Colorectal cancer is one among the most common type of cancer and is also third in cancer-related mortality. Currently, Capecitabine and Oxaliplatin (CAPOX) and 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) are one of the conventional adjuvant treatments of colorectal cancer.

[VIEW FULL PAPER]

[DOWNLOAD]

[Reference this Paper] [BACK]

Reference this Research Paper (copy & paste below code):

Karthika V Chandran, Maddili Manoj Kumar, Sankaraneni Manusha, Shirnam Shailja (2020); Comparison of Capox and Folfox with or Without Irinotecan in Colorectal Cancer; International Journal of Scientific and Research Publications (IJSRP) 10(08) (ISSN: 2250-3153), DOI: http://dx.doi.org/10.29322/IJSRP.10.08.2020.p10437